Literature DB >> 29300049

Hirschsprung disease - integrating basic science and clinical medicine to improve outcomes.

Robert O Heuckeroth1.   

Abstract

Hirschsprung disease is defined by the absence of enteric neurons at the end of the bowel. The enteric nervous system (ENS) is the intrinsic nervous system of the bowel and regulates most aspects of bowel function. When the ENS is missing, there are no neurally mediated propulsive motility patterns, and the bowel remains contracted, causing functional obstruction. Symptoms of Hirschsprung disease include constipation, vomiting, abdominal distension and growth failure. Untreated disease usually causes death in childhood because bloodstream bacterial infections occur in the context of bowel inflammation (enterocolitis) or bowel perforation. Current treatment is surgical resection of the bowel to remove or bypass regions where the ENS is missing, but many children have problems after surgery. Although the anatomy of Hirschsprung disease is simple, many clinical features remain enigmatic, and diagnosis and management remain challenging. For example, the age of presentation and the type of symptoms that occur vary dramatically among patients, even though every affected child has missing neurons in the distal bowel at birth. In this Review, basic science discoveries are linked to clinical manifestations of Hirschsprung disease, including partial penetrance, enterocolitis and genetics. Insights into disease mechanisms that might lead to new prevention, diagnostic and treatment strategies are described.

Entities:  

Mesh:

Year:  2018        PMID: 29300049     DOI: 10.1038/nrgastro.2017.149

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  179 in total

Review 1.  Genetically-targeted and conditionally-regulated ablation of astroglial cells in the central, enteric and peripheral nervous systems in adult transgenic mice.

Authors:  M V Sofroniew; T G Bush; N Blumauer; L Mucke; M H Johnson
Journal:  Brain Res       Date:  1999-07-17       Impact factor: 3.252

2.  SRY interference of normal regulation of the RET gene suggests a potential role of the Y-chromosome gene in sexual dimorphism in Hirschsprung disease.

Authors:  Yunmin Li; Tatsuo Kido; Maria M Garcia-Barcelo; Paul K H Tam; Z Laura Tabatabai; Yun-Fai Chris Lau
Journal:  Hum Mol Genet       Date:  2014-09-28       Impact factor: 6.150

3.  SOX10 mutations in patients with Waardenburg-Hirschsprung disease.

Authors:  V Pingault; N Bondurand; K Kuhlbrodt; D E Goerich; M O Préhu; A Puliti; B Herbarth; I Hermans-Borgmeyer; E Legius; G Matthijs; J Amiel; S Lyonnet; I Ceccherini; G Romeo; J C Smith; A P Read; M Wegner; M Goossens
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

Review 4.  Insights into the mechanisms underlying colonic motor patterns.

Authors:  Nick J Spencer; Phil G Dinning; Simon J Brookes; Marcello Costa
Journal:  J Physiol       Date:  2016-06-09       Impact factor: 5.182

Review 5.  Microbe-host interactions: Influence of the gut microbiota on the enteric nervous system.

Authors:  Niall P Hyland; John F Cryan
Journal:  Dev Biol       Date:  2016-06-22       Impact factor: 3.582

6.  Effect of increased intra-abdominal pressure on mesenteric arterial and intestinal mucosal blood flow.

Authors:  L N Diebel; S A Dulchavsky; R F Wilson
Journal:  J Trauma       Date:  1992-07

7.  Hirschsprung-associated congenital anomalies.

Authors:  A Sarioglu; F C Tanyel; N Büyükpamukçu; A Hiçsönmez
Journal:  Eur J Pediatr Surg       Date:  1997-12       Impact factor: 2.191

Review 8.  Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature.

Authors:  Marlene T Anderka; Angela E Lin; Dianne N Abuelo; Allen A Mitchell; Sonja A Rasmussen
Journal:  Am J Med Genet A       Date:  2009-06       Impact factor: 2.802

9.  Hirschsprung disease as a yet undescribed phenotype in a patient with ARID1B mutation.

Authors:  Toshiki Takenouchi; Hiroshi Yoshihashi; Yuri Sakaguchi; Tomoko Uehara; Masataka Honda; Takao Takahashi; Kenjiro Kosaki; Sahoko Miyama
Journal:  Am J Med Genet A       Date:  2016-08-11       Impact factor: 2.802

10.  Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence.

Authors:  Sales Ibiza; Bethania García-Cassani; Hélder Ribeiro; Tânia Carvalho; Luís Almeida; Rute Marques; Ana M Misic; Casey Bartow-McKenney; Denise M Larson; William J Pavan; Gérard Eberl; Elizabeth A Grice; Henrique Veiga-Fernandes
Journal:  Nature       Date:  2016-07-13       Impact factor: 49.962

View more
  59 in total

1.  37/67-laminin receptor facilitates neural crest cell migration during enteric nervous system development.

Authors:  Ming Fu; Amanda J Barlow-Anacker; Korah P Kuruvilla; Gary L Bowlin; Christopher W Seidel; Paul A Trainor; Ankush Gosain
Journal:  FASEB J       Date:  2020-06-27       Impact factor: 5.191

2.  Dlx1/2 mice have abnormal enteric nervous system function.

Authors:  Christina M Wright; James P Garifallou; Sabine Schneider; Heather L Mentch; Deepika R Kothakapa; Beth A Maguire; Robert O Heuckeroth
Journal:  JCI Insight       Date:  2020-02-27

Review 3.  Gut macrophages: key players in intestinal immunity and tissue physiology.

Authors:  Paul A Muller; Fanny Matheis; Daniel Mucida
Journal:  Curr Opin Immunol       Date:  2019-12-13       Impact factor: 7.486

4.  Resection margin histology may predict intermediate-term outcomes in children with rectosigmoid Hirschsprung disease.

Authors:  Lauren A Brooks; Kathryn L Fowler; Laura V Veras; Ming Fu; Ankush Gosain
Journal:  Pediatr Surg Int       Date:  2020-06-06       Impact factor: 1.827

5.  Redo surgery with longitudinal resection for dilated bowel in Hirschsprung disease: an illustrative case series.

Authors:  Daniëlle Roorda; Tessa J Surridge; Ruben G J Visschers; Joep P M Derikx; L W Ernest van Heurn
Journal:  Int J Colorectal Dis       Date:  2019-10-19       Impact factor: 2.571

Review 6.  Disorders of the enteric nervous system - a holistic view.

Authors:  Beate Niesler; Stefanie Kuerten; I Ekin Demir; Karl-Herbert Schäfer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-01-29       Impact factor: 46.802

7.  Muscularis macrophage development in the absence of an enteric nervous system.

Authors:  Marina Avetisyan; Julia E Rood; Silvia Huerta Lopez; Rajarshi Sengupta; Elizabeth Wright-Jin; Joseph D Dougherty; Edward M Behrens; Robert O Heuckeroth
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-17       Impact factor: 11.205

8.  Epigenetic factors Dnmt1 and Uhrf1 coordinate intestinal development.

Authors:  Julia Ganz; Ellie Melancon; Catherine Wilson; Angel Amores; Peter Batzel; Marie Strader; Ingo Braasch; Parham Diba; Julie A Kuhlman; John H Postlethwait; Judith S Eisen
Journal:  Dev Biol       Date:  2019-08-05       Impact factor: 3.582

9.  Dysregulation of the NRG1/ERBB pathway causes a developmental disorder with gastrointestinal dysmotility in humans.

Authors:  Thuy-Linh Le; Louise Galmiche; Jonathan Levy; Pim Suwannarat; Debby Mei Hellebrekers; Khomgrit Morarach; Franck Boismoreau; Tom Ej Theunissen; Mathilde Lefebvre; Anna Pelet; Jelena Martinovic; Antoinette Gelot; Fabien Guimiot; Amanda Calleroz; Cyril Gitiaux; Marie Hully; Olivier Goulet; Christophe Chardot; Severine Drunat; Yline Capri; Christine Bole-Feysot; Patrick Nitschké; Sandra Whalen; Linda Mouthon; Holly E Babcock; Robert Hofstra; Irenaeus Fm de Coo; Anne-Claude Tabet; Thierry J Molina; Boris Keren; Alice Brooks; Hubert Jm Smeets; Ulrika Marklund; Christopher T Gordon; Stanislas Lyonnet; Jeanne Amiel; Nadège Bondurand
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

10.  Robust, 3-Dimensional Visualization of Human Colon Enteric Nervous System Without Tissue Sectioning.

Authors:  Kahleb D Graham; Silvia Huerta López; Rajarshi Sengupta; Archana Shenoy; Sabine Schneider; Christina M Wright; Michael Feldman; Emma Furth; Federico Valdivieso; Amanda Lemke; Benjamin J Wilkins; Ali Naji; Edward J Doolin; Marthe J Howard; Robert O Heuckeroth
Journal:  Gastroenterology       Date:  2020-02-27       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.